Abstract
England’s PrEP Impact Trial ran between 2017 and 2020. This chapter centres on the policy events that first gave rise to the trial underpinned the trial’s genesis. Interviews with key stakeholders demonstrate that rather than achieving its aims as practical implementation trial that might have enabled and shared learning on the best ways to roll out PrEP, instead the Impact trial was designed and maintained as a ‘show trial’ to help manage a policy and financial impasse. Those interviewed tended to observe that because Impact’s power dynamics were rooted in traditional hierarchies about the production of evidence, this undermined its use as anything more than a stop-gap. Ultimately, rather than enabling the sharing of lessons for those planning the imminent launch of England’s future PrEP services, this trial’s legacy will instead be largely about the divisions and inequalities that it has exacerbated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Notable organisations involved nationally and internationally include: Porn4Prep, I Want PrEP Now, Prepster, ActUp London, Sophia Forum and United4PrEP.
- 2.
A few of those interviewed did note that a change in the clinical leadership part way through the study had brought some renewed opportunity for dialogue.
References
Azad, Y., Gold, D., & Smithson, K. (2018). Going to law for prep: A case study from England (poster). Presented at the international AIDS conference, National AIDS Trust, Amsterdam.
Camlin, C. S., & Seeley, J. (2018). Qualitative research on community experiences in large HIV research trials: What have we learned? Journal of the International AIDS Society, 21(S7), e25173. https://doi.org/10.1002/jia2.25173.
Deaton, A., & Cartwright, N. (2018). Understanding and misunderstanding randomized controlled trials. Social Science & Medicine, 210, 2–21. https://doi.org/10.1016/j.socscimed.2017.12.005.
Fassin, D. (2007). When bodies remember: Experiences and politics of AIDS in South Africa. Berkeley and Los Angeles: University of California Press.
Grant, R.M., Lama, J.R., Anderson, P.L., McMahan, V., Liu, A.Y., Vargas, L. et al. for the iPrEx study group. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. https://doi.org/10.1056/NEJMoa1011205
Holt, M. (2015). Configuring the users of new HIV-prevention technologies: The case of HIV pre-exposure prophylaxis. Culture, Health & Sexuality, 17(4), 428–439.
Kingori, P., & Sariola, S. (2015). Museum of failed HIV research. Anthropology & Medicine, 22(3), 213–216. https://doi.org/10.1080/13648470.2015.1079302.
Kippax, S., & Stephenson, N. (2016). Socialising the biomedical turn in HIV prevention. London and New York: Anthem Press.
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., et al. (2016). Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet, 387(10013), 53–60. https://doi.org/10.1016/S0140-6736(15)00056-2.
Molina, J-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., et al. for the ANRS IPERGAY Study Group. (2015). On-demand Preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373, 2237–2246.
Nagington, M., & Sandset, T. (2020). Putting the NHS England on trial: Uncertainty-as-power, evidence and the controversy of PrEP in England. Medical Humanities.https://doi.org/10.1136/medhum-2019-011780.
NHS England. (2016). NHS England announces major extension of national HIV prevention programme with Public Health England and funding for ten new specialised treatments [press release]. Retrieved August 21, 2020 www.england.nhs.uk/2016/12/hiv-prevention-pregramme/.
NHS England. (n.d.). PrEP trial updates. Retrieved July 13, 2020, from https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/.
Peters, D. H., Tran, N. T., Adam, T., & Alliance for Health Policy and Systems Research, World Health Organization (Eds.). (2013). Implementation research in health: A practical guide. Geneva: WHO.
Public Health England & Chelsea and Westminster Hospital NHS Foundation Trust. (2020). PrEP impact trial: Trial protocol v6.
Rhodes, T., & Lancaster, K. (2019). Evidence-making interventions in health: A conceptual framing. Social Science and Medicine, 238, 112488. https://doi.org/10.1016/j.socscimed.2019.112488.
Sandset, T., & Wieringa, S. (2019). Impure policies: Controversy in HIV prevention and the making of evidence. Critical Policy Studies.https://doi.org/10.1080/19460171.2019.1661865.
Stewart, J. (2019, July 5). Letter to NAT, THT and prepster on PrEP access. [Twitter] @NHSEngland. Retrieved August 19, 2020, from https://twitter.com/NHSEngland/status/1147170453586247680.
Wahlberg, A., & McGoey, L. (2007). An elusive evidence base: The construction and governance of randomized controlled trials. BioSocieties, 2, 1–10. https://doi.org/10.1017/S1745855207005017.
Young, I., Boydell, N., Patterson, C., Hilton, S., & McDaid, L. (2020). Configuring the PrEP user: Framing pre-exposure prophylaxix in UK newsprint 2012–2016. Culture, Health & Sexuality.https://doi.org/10.1080/13691058.2020.1729420.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dodds, C. (2021). Implementation Science or ‘Show’ Trial? England’s PrEP Impact Study. In: Bernays, S., Bourne, A., Kippax, S., Aggleton, P., Parker, R. (eds) Remaking HIV Prevention in the 21st Century. Social Aspects of HIV, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-030-69819-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-69819-5_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-69818-8
Online ISBN: 978-3-030-69819-5
eBook Packages: Social SciencesSocial Sciences (R0)